Gents, the value here is nothing to do with the cost of the (non)needle - when you get an injection, the vast majority of the revenue goes to the pharma company.
Pharma have many "elective" drugs stuck in their pipelines because the compounds can't be delivered in pills.
While I really hate needles, I'm still going to get my measles injections.
But nobody's going to inject me for my hair loss, obesity, well, even for flu for that matter.
This company is trying to solve the big pharma's problem of lost opportunities. How much is that worth?
- Forums
- ASX - By Stock
- NAL
- technology
technology, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)